Published in Int Immunol on August 19, 2009
Current progress in dengue vaccines. J Biomed Sci (2013) 1.16
The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease. PLoS One (2011) 0.86
The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2. Clin Vaccine Immunol (2011) 0.83
Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus. Am J Trop Med Hyg (2012) 0.78
Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections. Future Microbiol (2014) 0.78
The epidemiology of dengue in the americas over the last three decades: a worrisome reality. Am J Trop Med Hyg (2010) 4.09
Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis (2009) 2.26
Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol (2003) 2.22
IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol (2004) 1.50
HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol (2007) 1.29
A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates. Vaccine (2006) 1.24
Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol (2007) 1.23
Biological activity in vitro of anti-epidermal growth factor receptor monoclonal antibodies with different affinities. Hybridoma (Larchmt) (2007) 1.16
PCR detection of dengue virus using dried whole blood spotted on filter paper. J Virol Methods (2005) 1.14
Domain III of the envelope protein as a dengue vaccine target. Expert Rev Vaccines (2010) 1.10
Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis (2004) 1.10
IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections. Infect Dis Obstet Gynecol (2005) 1.08
Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides. Clin Immunol (2003) 1.07
Site-specific hydration dynamics in the nonpolar core of a molten globule by dynamic nuclear polarization of water. J Am Chem Soc (2011) 1.05
Lymphoplasmacytic myenteric, subepicardial, and pulmonary ganglioneuritis in four nonpsittacine birds. J Avian Med Surg (2007) 1.04
Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. Am J Trop Med Hyg (2010) 1.02
Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates. Antiviral Res (2008) 1.00
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo. Mol Cell Biochem (2008) 0.99
Utility of the aVL lead in the electrocardiographic diagnosis of atrioventricular node re-entrant tachycardia. Europace (2009) 0.99
[Economic impact of dengue 2 epidemic in Santiago de Cuba, 1997]. Rev Cubana Med Trop (2005) 0.98
Convergent linkage evidence from two Latin-American population isolates supports the presence of a susceptibility locus for bipolar disorder in 5q31-34. Hum Mol Genet (2006) 0.98
Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure. J Anat (2008) 0.97
Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2. Clin Vaccine Immunol (2007) 0.97
Diagnosis of dengue virus infection by the visual and simple AuBioDOT immunoglobulin M capture system. Clin Diagn Lab Immunol (2003) 0.97
Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells. Clin Cancer Res (2008) 0.97
Ethnicity and difference in dengue virus-specific memory T cell responses in Cuban individuals. Viral Immunol (2006) 0.95
[Dengue and hemorrhagic dengue in the Americas]. Rev Panam Salud Publica (2007) 0.95
Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice. Virus Res (2006) 0.94
Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic. Int J Infect Dis (2008) 0.93
Experience with using second life for medical education in a family and community medicine education unit. BMC Med Educ (2012) 0.93
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice. Virology (2009) 0.93
Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteins. Arch Virol (2008) 0.93
[Society, economy, inequities and dengue]. Rev Cubana Med Trop (2013) 0.92
Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate. Hum Hered (2008) 0.92
Long-term memory cellular immune response to dengue virus after a natural primary infection. Int J Infect Dis (2002) 0.91
JPEG2000 for automated quantification of immunohistochemically stained cell nuclei: a comparative study with standard JPEG format. Virchows Arch (2010) 0.90
The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model. Viral Immunol (2009) 0.88
Association of MICA and MICB alleles with symptomatic dengue infection. Hum Immunol (2011) 0.88
Antibody responses to Asian and American genotypes of dengue 2 virus in immunized mice. Clin Diagn Lab Immunol (2005) 0.87
A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice. J Virol Methods (2004) 0.87
Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris. Am J Trop Med Hyg (2003) 0.87
Oxidative stress in adult dengue patients. Am J Trop Med Hyg (2004) 0.87
Viremia and the magnitude of the immune response upon infection of green monkeys with dengue virus type 2 are strain-dependent. Curr Microbiol (2009) 0.86
A myocarditis outbreak with fatal cases associated with adenovirus subgenera C among children from Havana City in 2005. J Clin Virol (2008) 0.86
Putative association of the carboxy-terminal PDZ ligand of neuronal nitric oxide synthase gene (CAPON) with schizophrenia in a Colombian population. Schizophr Res (2005) 0.86
Viremia and antibody response in green monkeys (Chlorocebus aethiops sabaeus) infected with dengue virus type 2: a potential model for vaccine testing. Microbiol Immunol (2009) 0.85
Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis. Vaccine (2008) 0.85
Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds. Int Wound J (2006) 0.85
The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2. Clin Vaccine Immunol (2011) 0.83
A fragment of the envelope protein from dengue-1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in mice. Biotechnol Appl Biochem (2004) 0.83